Published in Infect Immun on January 19, 2010
Causes of variation in malaria infection dynamics: insights from theory and data. Am Nat (2011) 0.97
Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response. PLoS Negl Trop Dis (2012) 0.95
Parasite-driven pathogenesis in Trypanosoma brucei infections. Parasite Immunol (2011) 0.92
The within-host dynamics of African trypanosome infections. Philos Trans R Soc Lond B Biol Sci (2015) 0.87
Trypanosoma vivax GM6 antigen: a candidate antigen for diagnosis of African animal trypanosomosis in cattle. PLoS One (2013) 0.85
A comparison of two distinct murine macrophage gene expression profiles in response to Leishmania amazonensis infection. BMC Microbiol (2012) 0.83
The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense. PLoS One (2013) 0.77
Role of cytokines in Trypanosoma brucei-induced anaemia: A review of the literature. Malawi Med J (2015) 0.75
An Overview of Trypanosoma brucei Infections: An Intense Host-Parasite Interaction. Front Microbiol (2016) 0.75
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol (2006) 13.13
Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett (2004) 11.00
Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp Parasitol (1970) 8.21
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med (2003) 6.21
The trypanosomiases. Lancet (2003) 5.96
A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science (2006) 4.44
Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science (2006) 4.23
LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell (2004) 4.20
Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J Leukoc Biol (2002) 3.89
Human African trypanosomiasis (sleeping sickness): epidemiological update. Wkly Epidemiol Rec (2006) 3.75
The burden of human African trypanosomiasis. PLoS Negl Trop Dis (2008) 2.53
FIZZ1 and Ym as tools to discriminate between differentially activated macrophages. Dev Immunol (2002) 2.36
The importance of the spleen in malaria. Trends Parasitol (2005) 2.23
Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci U S A (2004) 2.18
Identification of quantitative trait loci controlling acute virulence in Toxoplasma gondii. Proc Natl Acad Sci U S A (2002) 1.92
Susceptibility of inbred strains of mice to Trypanosoma congolense: correlation with changes in spleen lymphocyte populations. Clin Exp Immunol (1978) 1.90
Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice. J Immunol (2006) 1.76
Host susceptibility to African trypanosomiasis: trypanotolerance. Adv Parasitol (1982) 1.75
Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood (2000) 1.65
Mapping of quantitative trait loci controlling trypanotolerance in a cross of tolerant West African N'Dama and susceptible East African Boran cattle. Proc Natl Acad Sci U S A (2003) 1.60
The anemia of malaria infection: role of inflammatory cytokines. Curr Hematol Rep (2004) 1.53
Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis. J Infect Dis (2001) 1.46
Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood (2006) 1.43
Bovine trypanotolerance: A natural ability to prevent severe anaemia and haemophagocytic syndrome? Int J Parasitol (2006) 1.43
Sleeping sickness survey in the Serengeti area (Tanzania) 1971. I. Examination of large mammals for trypanosomes. Acta Trop (1973) 1.39
Resistance to the African trypanosomes is IFN-gamma dependent. J Immunol (1998) 1.38
Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infect Immun (1999) 1.36
IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection. J Immunol (2009) 1.35
Erythroid Kruppel-like factor (EKLF) coordinates erythroid cell proliferation and hemoglobinization in cell lines derived from EKLF null mice. Blood (2001) 1.34
The genetic map and comparative analysis with the physical map of Trypanosoma brucei. Nucleic Acids Res (2005) 1.33
Alternatively activated macrophages in protozoan infections. Curr Opin Immunol (2007) 1.30
Antigenic variation in the African trypanosome: molecular mechanisms and phenotypic complexity. Cell Microbiol (2009) 1.28
Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses. PLoS Pathog (2008) 1.27
Replication, differentiation, growth and the virulence of Trypanosoma brucei infections. Parasitology (1995) 1.27
Headpiece domain of dematin is required for the stability of the erythrocyte membrane. Proc Natl Acad Sci U S A (2002) 1.26
The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages. J Biol Chem (2006) 1.24
Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation. Blood (2007) 1.23
Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response. J Infect Dis (2007) 1.22
Severity of human african trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile. Infect Immun (2004) 1.21
Simultaneous host and parasite expression profiling identifies tissue-specific transcriptional programs associated with susceptibility or resistance to experimental cerebral malaria. BMC Genomics (2006) 1.20
IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis. Cell Immunol (1999) 1.19
IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J Immunol (1996) 1.18
Localization of genes controlling resistance to trypanosomiasis in mice. Nat Genet (1997) 1.17
Trypanosome variant surface glycoprotein transfer to target membranes: a model for the pathogenesis of trypanosomiasis. Proc Natl Acad Sci U S A (1990) 1.16
Alternatively activated myeloid cells limit pathogenicity associated with African trypanosomiasis through the IL-10 inducible gene selenoprotein P. J Immunol (2008) 1.16
Transcriptional profiling reveals suppressed erythropoiesis, up-regulated glycolysis, and interferon-associated responses in murine malaria. J Infect Dis (2004) 1.14
Bone marrow nitric oxide production and development of anemia in Trypanosoma brucei-infected mice. Infect Immun (1995) 1.12
Trypanosoma congolense: inheritance of susceptibility to infection in inbred strains of mice. Exp Parasitol (1979) 1.11
Taxonomy of the sleeping sickness trypanosomes. J Parasitol (1967) 1.09
African trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance by limiting pathology associated with sustained type 1 inflammation. J Immunol (2007) 1.09
Differences in the transcriptional responses induced by Theileria annulata infection in bovine monocytes derived from resistant and susceptible cattle breeds. Int J Parasitol (2007) 1.09
P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis. J Infect Dis (2004) 1.08
Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol (2003) 1.07
Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes. J Neuroimmunol (2006) 1.03
Trypanosoma brucei rhodesiense: characterisation of stocks from Zambia, Kenya, and Uganda using repetitive DNA probes. Exp Parasitol (1991) 1.02
Virulence and pathogenicity patterns of Trypanosoma brucei gambiense field isolates in experimentally infected mouse: differences in host immune response modulation by secretome and proteomics. Microbes Infect (2007) 1.02
Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J Immunol (1996) 1.00
TNF-alpha mediates the development of anaemia in a murine Trypanosoma brucei rhodesiense infection, but not the anaemia associated with a murine Trypanosoma congolense infection. Clin Exp Immunol (2005) 0.99
African trypanosomosis: from immune escape and immunopathology to immune intervention. Vet Parasitol (2007) 0.98
Mechanisms controlling anaemia in Trypanosoma congolense infected mice. PLoS One (2009) 0.98
Role of iron homeostasis in trypanosomiasis-associated anemia. Immunobiology (2008) 0.96
Trypanosoma brucei infection elicits nitric oxide-dependent and nitric oxide-independent suppressive mechanisms. J Leukoc Biol (1998) 0.94
Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice. Infect Immun (2002) 0.94
Responses of bovine chimaeras combining trypanosomosis resistant and susceptible genotypes to experimental infection with Trypanosoma congolense. Vet Parasitol (2003) 0.91
Serological studies of trypanosomiasis in East Africa. II. Comparisons of antigenic types of Trypanosoma brucei subgroup organisms isolated from wild tsetse flies. Ann Trop Med Parasitol (1973) 0.91
Association between human African trypanosomiasis and the IL6 gene in a Congolese population. Infect Genet Evol (2006) 0.90
Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo. Proc Natl Acad Sci U S A (1994) 0.88
Application of flow cytometric techniques to veterinary clinical hematology. Vet Clin Pathol (2002) 0.88
Transcriptional profiling of cattle infected with Trypanosoma congolense highlights gene expression signatures underlying trypanotolerance and trypanosusceptibility. BMC Genomics (2009) 0.88
Susceptibility of heat shock protein 70.1-deficient C57BL/6 J, wild-type C57BL/6 J and A/J mice to Trypanosoma congolense infection. Parasitol Res (2003) 0.87
A major genetic locus in Trypanosoma brucei is a determinant of host pathology. PLoS Negl Trop Dis (2009) 0.87
Cytokine mRNA profiling of peripheral blood mononuclear cells from trypanotolerant and trypanosusceptible cattle infected with Trypanosoma congolense. Physiol Genomics (2006) 0.87
Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy. Infect Immun (2009) 0.86
Understanding the role of monocytic cells in liver inflammation using parasite infection as a model. Immunobiology (2009) 0.86
Susceptibility of N'Dama and Boran cattle to tsetse-transmitted primary and rechallenge infections with a homologous serodeme of Trypanosoma congolense. Parasite Immunol (1991) 0.86
Pathogenesis of the anemia in african trypanosomiasis: characterization and purification of a hemolytic factor. Schweiz Med Wochenschr (1975) 0.85
Demonstration of erythrophagocytosis in Trypanosoma congolense-infected goats. Vet Parasitol (2001) 0.84
Gene expression profiling in a mouse model for African trypanosomiasis. Genes Immun (2006) 0.82
Developmental expression of mouse erythrocyte protein 4.2 mRNA: evidence for specific expression in erythroid cells. Blood (1998) 0.79
Both type-I and type-II responses contribute to murine trypanotolerance. J Vet Med Sci (2009) 0.79
In vitro erythrophagocytosis by cultured macrophages stimulated with extraneous substances and those isolated from the blood, spleen and bone marrow of Boran and N'Dama cattle infected with Trypanosoma congolense and Trypanosoma vivax. Onderstepoort J Vet Res (2000) 0.78
Susceptibility to African trypanosomiasis of N'Dama and Zebu cattle in an area of Glossina morsitans submorsitans challenge. Vet Rec (1981) 0.78
The genome of the African trypanosome Trypanosoma brucei. Science (2005) 11.48
A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science (2005) 5.99
The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis. PLoS Negl Trop Dis (2010) 1.83
Population structures and the role of genetic exchange in the zoonotic pathogen Cryptosporidium parvum. J Mol Evol (2003) 1.64
Multilocus genotyping of Cryptosporidium parvum Type 2: population genetics and sub-structuring. Infect Genet Evol (2003) 1.60
Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor. Proc Natl Acad Sci U S A (2010) 1.43
Allelic segregation and independent assortment in T. brucei crosses: proof that the genetic system is Mendelian and involves meiosis. Mol Biochem Parasitol (2005) 1.42
Plasmodium interspersed repeats: the major multigene superfamily of malaria parasites. Nucleic Acids Res (2004) 1.34
The genetic map and comparative analysis with the physical map of Trypanosoma brucei. Nucleic Acids Res (2005) 1.33
The DNA sequence of chromosome I of an African trypanosome: gene content, chromosome organisation, recombination and polymorphism. Nucleic Acids Res (2003) 1.33
A large gene family for putative variant antigens shared by human and rodent malaria parasites. Proc Biol Sci (2002) 1.23
Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response. J Infect Dis (2007) 1.22
Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs. J Antimicrob Chemother (2013) 1.18
Digital gene expression analysis of two life cycle stages of the human-infective parasite, Trypanosoma brucei gambiense reveals differentially expressed clusters of co-regulated genes. BMC Genomics (2010) 1.16
The sequence and analysis of Trypanosoma brucei chromosome II. Nucleic Acids Res (2003) 1.14
Trypanosoma brucei gambiense Type 1 populations from human patients are clonal and display geographical genetic differentiation. Infect Genet Evol (2008) 1.10
Tools for investigating the environmental transmission of Cryptosporidium and Giardia infections in humans. Trends Parasitol (2006) 1.10
Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1. PLoS Negl Trop Dis (2011) 1.09
Discovery of mating in the major African livestock pathogen Trypanosoma congolense. PLoS One (2009) 1.06
The population structure of the Cryptosporidium parvum population in Scotland: a complex picture. Infect Genet Evol (2007) 1.06
Multilocus analysis of Cryptosporidium hominis and Cryptosporidium parvum isolates from sporadic and outbreak-related human cases and C. parvum isolates from sporadic livestock cases in the United Kingdom. J Clin Microbiol (2007) 1.06
Age-related and infection intensity-related shifts in antibody recognition of defined protein antigens in a schistosome-exposed population. J Infect Dis (2008) 1.05
Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection. J Virol (2011) 1.04
Epidemiological analysis of tick-borne diseases in Zambia. Vet Parasitol (2010) 1.02
Evolution and diversity of secretome genes in the apicomplexan parasite Theileria annulata. BMC Genomics (2010) 1.02
Use of multiple displacement amplification to increase the detection and genotyping of trypanosoma species samples immobilized on FTA filters. Am J Trop Med Hyg (2007) 1.01
Genetic analysis of the human infective trypanosome Trypanosoma brucei gambiense: chromosomal segregation, crossing over, and the construction of a genetic map. Genome Biol (2008) 1.00
Evidence of host-associated populations of Cryptosporidium parvum in Italy. Appl Environ Microbiol (2012) 0.99
Visualisation and analysis of proteomic data from the procyclic form of Trypanosoma brucei. Proteomics (2006) 0.98
The TgsGP gene is essential for resistance to human serum in Trypanosoma brucei gambiense. PLoS Pathog (2013) 0.96
Genetic analysis of phenotype in Trypanosoma brucei: a classical approach to potentially complex traits. Philos Trans R Soc Lond B Biol Sci (2002) 0.96
First evidence that parasite infecting apparent aparasitemic serological suspects in human African trypanosomiasis are Trypanosoma brucei gambiense and are similar to those found in patients. Infect Genet Evol (2011) 0.95
Trypanosoma vivax displays a clonal population structure. Int J Parasitol (2009) 0.95
Evaluation of cytochrome b as a sensitive target for PCR based detection of T. annulata carrier animals. Vet Parasitol (2010) 0.95
An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate. J Virol (2013) 0.94
Trypanosoma evansi: genetic variability detected using amplified restriction fragment length polymorphism (AFLP) and random amplified polymorphic DNA (RAPD) analysis of Kenyan isolates. Exp Parasitol (2006) 0.91
Whole-genome sequencing of Trypanosoma brucei reveals introgression between subspecies that is associated with virulence. MBio (2013) 0.90
Genetic exchange in Trypanosoma brucei: evidence for mating prior to metacyclic stage development. Mol Biochem Parasitol (2006) 0.89
Population genetics of Trypanosoma brucei rhodesiense: clonality and diversity within and between foci. PLoS Negl Trop Dis (2013) 0.89
Theileria parva genetic diversity and haemoparasite prevalence in cattle and wildlife in and around Lake Mburo National Park in Uganda. Parasitol Res (2010) 0.89
Trypanosomosis in The Gambia: prevalence in working horses and donkeys detected by whole genome amplification and PCR, and evidence for interactions between trypanosome species. BMC Vet Res (2008) 0.89
Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes. Eukaryot Cell (2009) 0.88
Development of a multiplex PCR assay for simultaneous detection of Theileria annulata, Babesia bovis and Anaplasma marginale in cattle. Exp Parasitol (2012) 0.87
A major genetic locus in Trypanosoma brucei is a determinant of host pathology. PLoS Negl Trop Dis (2009) 0.87
Amplified (restriction) fragment length polymorphism (AFLP) analysis. Methods Mol Biol (2004) 0.84
Human and animal Trypanosomes in Côte d'Ivoire form a single breeding population. PLoS One (2013) 0.84
Novel African trypanocidal agents: membrane rigidifying peptides. PLoS One (2012) 0.83
Trypanosoma brucei cathepsin-L increases arrhythmogenic sarcoplasmic reticulum-mediated calcium release in rat cardiomyocytes. Cardiovasc Res (2013) 0.82
Population genetic analysis and sub-structuring in Babesia bovis. Mol Biochem Parasitol (2011) 0.82
Role of expression site switching in the development of resistance to human Trypanosome Lytic Factor-1 in Trypanosoma brucei brucei. Mol Biochem Parasitol (2011) 0.77
Analysis of host genetic factors influencing African trypanosome species infection in a cohort of Tanzanian Bos indicus cattle. Vet Parasitol (2011) 0.77
A proteomic analysis of arsenical drug resistance in Trypanosoma brucei. Proteomics (2006) 0.77
Exploiting genetic variation to discover genes involved in important disease phenotypes. Methods Mol Biol (2015) 0.75
Case of Nigeria-Acquired Human African Trypanosomiasis in United Kingdom, 2016. Emerg Infect Dis (2017) 0.75